X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (722) 722
male (467) 467
female (437) 437
middle aged (413) 413
adult (386) 386
aged (339) 339
oncology (318) 318
prognosis (286) 286
hematology (224) 224
index medicus (215) 215
lymphomas (214) 214
antineoplastic combined chemotherapy protocols - therapeutic use (198) 198
non-hodgkins-lymphoma (188) 188
lymphoma (181) 181
adolescent (175) 175
chemotherapy (170) 170
lymphoma, non-hodgkin - mortality (143) 143
aged, 80 and over (133) 133
cancer (133) 133
survival rate (132) 132
survival analysis (127) 127
retrospective studies (124) 124
pathology (122) 122
treatment outcome (120) 120
neoplasm staging (119) 119
lymphoma, non-hodgkin - pathology (117) 117
non-hodgkin's lymphomas (110) 110
lymphoma, large b-cell, diffuse - mortality (108) 108
combined modality therapy (101) 101
disease-free survival (98) 98
non-hodgkin's lymphoma (96) 96
lymphoma, non-hodgkin - drug therapy (94) 94
lymphoma, non-hodgkin - therapy (93) 93
survival (91) 91
b-cell lymphoma (84) 84
child (84) 84
lymphoma - pathology (84) 84
risk factors (83) 83
cyclophosphamide - administration & dosage (79) 79
medicine & public health (79) 79
lymphoma, large b-cell, diffuse - pathology (78) 78
doxorubicin - administration & dosage (72) 72
follow-up studies (71) 71
classification (69) 69
diagnosis (69) 69
epstein-barr-virus (69) 69
lymphoma - mortality (69) 69
vincristine - administration & dosage (68) 68
care and treatment (67) 67
transplantation (67) 67
disease (65) 65
therapy (64) 64
remission induction (61) 61
lymphoma - therapy (58) 58
prednisone - administration & dosage (58) 58
health aspects (57) 57
immunohistochemistry (56) 56
antineoplastic combined chemotherapy protocols - administration & dosage (55) 55
lymphoma, large b-cell, diffuse - drug therapy (55) 55
leukemia (54) 54
incidence (53) 53
prognostic factors (53) 53
radiotherapy (51) 51
immunophenotyping (50) 50
t cells (50) 50
aids (49) 49
time factors (49) 49
antineoplastic combined chemotherapy protocols - adverse effects (48) 48
malignant-lymphoma (48) 48
tumors (48) 48
rituximab (47) 47
child, preschool (46) 46
hiv (46) 46
immunology (46) 46
recurrence (46) 46
research (46) 46
bone-marrow transplantation (44) 44
cyclophosphamide - therapeutic use (44) 44
large-cell lymphoma (44) 44
age factors (42) 42
lymphoma, non-hodgkin - epidemiology (42) 42
diffuse large b-cell lymphoma (41) 41
doxorubicin - therapeutic use (41) 41
prednisone - therapeutic use (41) 41
vincristine - therapeutic use (41) 41
non-hodgkin lymphoma (39) 39
transplantation, autologous (39) 39
analysis (38) 38
animals (38) 38
lymphoma, b-cell - pathology (38) 38
young adult (38) 38
combination chemotherapy (37) 37
lymphoma, large b-cell, diffuse - therapy (37) 37
medicine, general & internal (37) 37
lymphoma - drug therapy (36) 36
lymphoma, b-cell - mortality (36) 36
biopsy (35) 35
cyclophosphamide (35) 35
expression (35) 35
diagnosis, differential (34) 34
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (886) 886
Japanese (5) 5
Spanish (4) 4
French (2) 2
German (2) 2
Hebrew (1) 1
Romanian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Hematology, ISSN 0361-8609, 12/2014, Volume 89, Issue 12, pp. 1116 - 1120
Journal Article
American Journal of Clinical Pathology, ISSN 0002-9173, 06/2012, Volume 137, Issue 6, pp. 879 - 889
Journal Article
Journal Article
Blood, ISSN 0006-4971, 04/1997, Volume 89, Issue 7, pp. 2291 - 2297
Among high-grade malignant non-Hodgkin's lymphomas the updated Kiel classification identifies three major B-cell entities: centroblastic (CB), B-immunoblastic... 
MULTICENTER TRIAL | BONE-MARROW TRANSPLANTATION | NEOPLASMS | DISEASE | NON-HODGKINS-LYMPHOMA | GRADE | POLYMERASE CHAIN-REACTION | PROPOSAL | STANDARD REGIMEN CHOP | HEMATOLOGY | CHEMOTHERAPY | Procarbazine - administration & dosage | Multivariate Analysis | Cyclophosphamide - administration & dosage | Prognosis | Prospective Studies | Age Factors | Lymphoma, Large-Cell, Anaplastic - radiotherapy | Humans | Middle Aged | Lymphoma, Large-Cell, Immunoblastic - mortality | Male | Life Tables | Lymphoma, Large-Cell, Immunoblastic - radiotherapy | Vincristine - administration & dosage | Adult | Female | Radiotherapy, Adjuvant | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Factors | Etoposide - administration & dosage | Treatment Outcome | Combined Modality Therapy | Bleomycin - administration & dosage | Lymphoma, Large B-Cell, Diffuse - radiotherapy | Lymphoma, Large-Cell, Anaplastic - mortality | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, Large B-Cell, Diffuse - classification | Lymphoma, Large-Cell, Anaplastic - drug therapy | Adolescent | Survival Analysis | Lymphoma, Large-Cell, Immunoblastic - drug therapy | Methotrexate - administration & dosage | Aged
Journal Article
Leukemia, ISSN 0887-6924, 2004, Volume 18, Issue 1, pp. 146 - 155
Journal Article
The American Journal of Medicine, ISSN 0002-9343, 2001, Volume 111, Issue 9, pp. 704 - 711
Journal Article
Hematology/Oncology and Stem Cell Therapy, ISSN 1658-3876, 2010, Volume 3, Issue 1, pp. 7 - 12
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 2002, Volume 43, Issue 1, pp. 97 - 104
Journal Article
Hematology Journal, ISSN 1466-4860, 2001, Volume 2, Issue 3, pp. 172 - 179
Primary effusion lymphoma is a rare type of B-cell lymphoproliferative disorder which is mainly observed in patients with HIV infection. Lymphomatous cells... 
HHV-8 | HIV-associated B-cell lymphoma | Primary effusion lymphoma | KSHV | Doxorubicin - therapeutic use | Cyclophosphamide - administration & dosage | Humans | Lymphoma, AIDS-Related - etiology | Middle Aged | Lymphoma, Large-Cell, Immunoblastic - mortality | Male | Viral Load | Karyotyping | Cytosine - therapeutic use | Lymphoma, B-Cell - etiology | Lymphoma, Large-Cell, Immunoblastic - virology | Antiviral Agents - therapeutic use | Organophosphorus Compounds - therapeutic use | Etoposide - administration & dosage | Bleomycin - administration & dosage | Lymphoma, Large-Cell, Immunoblastic - etiology | Remission Induction | Herpesviridae Infections - drug therapy | Gene Rearrangement, B-Lymphocyte, Heavy Chain | Survival Analysis | Vincristine - therapeutic use | Lymphoma, Large-Cell, Immunoblastic - drug therapy | Methotrexate - administration & dosage | Prednisone - therapeutic use | Cytosine - analogs & derivatives | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Lymphoma, B-Cell - genetics | Cyclophosphamide - therapeutic use | Lymphoma, AIDS-Related - mortality | Herpesvirus 8, Human - isolation & purification | Herpesvirus 8, Human - pathogenicity | Polymerase Chain Reaction | Adult | Anti-HIV Agents - therapeutic use | Lymphoma, B-Cell - virology | Drug Therapy, Combination | Doxorubicin - administration & dosage | Lymphoma, AIDS-Related - virology | Lymphoma, B-Cell - drug therapy | Lymphoma, AIDS-Related - drug therapy | Prednisone - administration & dosage | Lymphoma, B-Cell - mortality | Interferon-alpha - therapeutic use | Immunophenotyping | Lymphoma, AIDS-Related - genetics | Herpesviridae Infections - virology | Organophosphonates | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chromosome Aberrations | Vindesine - administration & dosage | Lymphoma, Large-Cell, Immunoblastic - genetics
Journal Article
American Journal of Clinical Pathology, ISSN 0002-9173, 1994, Volume 101, Issue 3, pp. 305 - 311
Journal Article
Journal Article
18.